U.S. markets close in 1 hour 19 minutes

BioLargo, Inc. (BLGO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1742+0.0002 (+0.11%)
As of 2:21PM EDT. Market open.

BioLargo, Inc.

14921 Chestnut Street
Westminster, CA 92683
United States
888 400 2863
http://www.biolargo.com

Sector(s)Basic Materials
IndustryChemicals
Full Time Employees27

Key Executives

NameTitlePayExercisedYear Born
Mr. Dennis P. CalvertChairman, Pres & CEO320.3kN/A1963
Mr. Charles K. Dargan II, C.F.A.Chief Financial OfficerN/AN/A1955
Mr. Joseph L. ProvenzanoExec. VP of Operations, Corp. Sec. & Director186.56kN/A1969
Mr. Kenneth Reay CodeChief Science Officer & Director301.2kN/A1947
Dr. Tanya Rhodes Ph.D.Chief Technology Officer of Clyra Medical TechnologiesN/AN/AN/A
Mr. Steven V. Harrison IIPres of Clyra Medical Technologies IncN/AN/A1959
Mr. Randall MoorePres of BioLargo Engineering, Science & TechnologiesN/AN/AN/A
Dr. Richard SmithPres of BioLargo WaterN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

BioLargo, Inc. invents, develops, and commercializes various platform technologies. The company's technologies solve challenging environmental problems comprising per- and polyfluoroalkyl substances contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. It holds various issued patents, maintains a pipeline of products, and provides full-service environmental engineering services. The company's products include Advanced Oxidation system, a water treatment device that generates a series of oxidative species of iodine and other molecules; Aqueous Electrostatic Concentrator, a water treatment system that removes per- and polyfluoroalkyl substances from water; CupriDyne Clean industrial products, which reduce and eliminate tough odors and volatile organic compounds in various industrial settings; and Clyra advanced wound care products. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.

Corporate Governance

BioLargo, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.